Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Home-measured orthostatic hypotension associated with cerebral small vessel disease in a community-based older population

Abstract

This study aimed to investigate the relationship between cerebral small vessel disease (CSVD) and orthostatic hypotension (OH) using self-measured blood pressure at home in community-dwelling older subjects. Between May 2016 and October 2018, 663 community-dwelling adults aged ≥60 years were enrolled in Shandong, China. CSVD, including white matter hyperintensities (WMHs), lacunes, enlarged Virchow–Robin spaces (EVRS) and microbleeds, was assessed using brain magnetic resonance imaging. After receiving appropriate training, the subjects participated in “home-measured (H)OH” by themselves for three consecutive days. Participants were classified into no-HOH, 1 HOH, and ≥2 HOH episode groups according to the presence of HOH episodes. The WMH volume, WMH-to-total intracranial volume (TIV) ratio, total numbers of lacunes and EVRS, and prevalence of Fazekas scale score ≥2, lacunes, and EVRS were elevated in the 1 and ≥2 HOH episode groups compared with the no-HOH episode group (P < 0.05). The prevalence and total number of microbleeds were significantly higher in the ≥2 HOH episodes group than in the no-HOH and 1 HOH episode groups (P < 0.05). HOH episodes were significantly associated with WMH volume, WMH-to-TIV ratio, and the total numbers of lacunes, EVRS, and microbleeds after adjustment for confounders (P < 0.05). The risks of Fazekas scale score ≥2, lacunes, EVRS, and microbleeds were 2.123-, 1.893-, 2.162-, and 1.656-fold higher in the 1 HOH episode group and 4.910-, 5.359-, 3.048-, and 2.418-fold higher in the ≥2 HOH episodes group, respectively, than those in the no-HOH group. The presence of HOH episodes was an independent risk factor for CSVD in the community-based older population.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Wardlaw JM, Smith C, Dichans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483–97.

    PubMed  Google Scholar 

  2. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R.Standards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol.2013;12:822–38.

    PubMed  PubMed Central  Google Scholar 

  3. Cannistraro RJ, Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF. CNS small vessel disease: a clinical review. Neurology. 2019;92:1146–56.

    PubMed  PubMed Central  Google Scholar 

  4. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam scan study. J Neurol Neurosurg Psychiatry. 2011;70:9–14.

    Google Scholar 

  5. Poels MM, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van der Lugt A, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke. 2010;41:S103–6.

  6. Hilal S, Mok V, Youn YC, Wong A, Ikram MK, Chen CL. Prevalence, risk factors and consequences of cerebral small vessel disease: data from three Asian countries. J Neurol Neurosurg Psychiatry. 2017;88:669–74.

    PubMed  Google Scholar 

  7. Hilal S, Baaij LGA, de Groot M, Niessen WJ, Ikram MK, Ikram MA, et al. Prevalence and clinical relevance of diffusion-weighted imaging lesions: the Rotterdam study. Neurology. 2019;93:e1058–67.

    PubMed  Google Scholar 

  8. Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H.LADIS Study Group et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (Leukoaraiosis and disability) study cohort. BMJ. 2009;339:b2477.

    PubMed  PubMed Central  Google Scholar 

  9. Goldstein ED, Badi MK, Hasan TF, Lesser ER, Hodge DO, Lin MP, et al. Cerebral small vessel disease burden and all-cause mortality: Mayo clinic florida familial cerebrovascular diseases registry. J Stroke Cerebroavasc Dis. 2019;28:104285.

    Google Scholar 

  10. Havlik RJ, Foley DJ, Sayer B, Masaki K, White L, Launer LJ. Variability in midlife systolic blood pressure is related to late-life white matter lesions: the Honolulu-Asia Aging study. Stroke. 2002;33:26–30.

    PubMed  Google Scholar 

  11. Zhang H, Cui Y, Zhao Y, Dong Y, Wang J, Duan D, et al. Association of circadian rhythm of blood pressure and cerebral small vessel disease in community-based elderly population. J Gerontol A Biol Sci Med Sci. 2019;74:1322–30.

    PubMed  Google Scholar 

  12. Liu Z, Zhao Y, Zhang H, Chai Q, Cui Y, Diao Y, et al. Excessive variability in systolic blood pressure that is self-measured at home exacerbates the progression of brain white matter lesions and cognitive impairment in the oldest old. Hypertens Res. 2016;39:245–53.

    PubMed  Google Scholar 

  13. Matsubayashi K, Okumiya K, Wada T, Osaki Y, Fujisawa M, Doi Y, et al. Postural dysregulation in systolic blood pressure is associated with worsened scoring on neurobehavioral function tests and leukoaraiosis in the older elderly living in a community. Stroke. 1997;28:2169–73.

    CAS  PubMed  Google Scholar 

  14. Soennesyn H, Nilsen DW, Oppedal K, Greve OJ, Beyer MK, Aarsland D. Relationship between orthostatic hypotension and white matter hyperintensity load in older patients with mild dementia. PLoS ONE. 2012;7:e52196.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Kario K, Eguchi K, Hoshide S, Hoshide Y, Umeda Y, Mitsuhashi T, et al. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a new cardiovascular risk factor. J Am Coll Cardiol. 2002;40:133–41.

    PubMed  Google Scholar 

  16. Foster-Dingley JC, Moonen JEF, de Ruijter W, van der Mast RC, van der Grond J. Orthostatic hypotension in older persons is not associated with cognitive functioning, features of cerebral damage or cerebral blood flow. J Hypertens. 2018;36:1201–6.

    CAS  PubMed  Google Scholar 

  17. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurololgy. 1996;46:1470.

    Google Scholar 

  18. McNicholas T, Tobin K, Carey D, O’Callaghan S, Kenny RA. Is baseline orthostatic hypotension associated with a decline in global cognitive performance at 4-year follow-up? Data from TILDA (The Irish Longitudinal Study on Ageing). J Am Heart Assoc. 2018;7:e008976.

    PubMed  PubMed Central  Google Scholar 

  19. Suemoto CK, Baena CP, Mill JG, Santos IS, Lotufo PA, Benseñor I. Orthostatic hypotension and cognitive function: cross-results from the ELSA-Brasil study. J Gerontol A Biol Sci Med Sci. 2019;74:358–65.

    PubMed  Google Scholar 

  20. Peters R, Anstey KJ, Booth A, Beckett N, Warwick J, Antikainen R, et al. Orthostatic hypotension and symptomatic subclinical orthostatic hypotension increase risk of cognitive impairment: an integrated evidence review and analysis of a large older adult hypertensive cohort. Eur Heart J. 2018;39:3135–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol. 2015;66:848–60.

    PubMed  Google Scholar 

  22. Finucane C, O’Connell MD, Fan CW, Savva GM, Soraghan CJ, Nolan H, et al. Age-related normative changes in phasic orthostatic blood pressure in a large population study: findings from the Irish Longitudinal Study on Ageing (TILDA). Circulation. 2014;130:1780–9.

    PubMed  Google Scholar 

  23. Xin W, Lin Z, Mi S. Orthostatic hypotension and mortality risk: a meta-analysis of cohort studies. Heart. 2014;100:406–13.

    PubMed  Google Scholar 

  24. Angelousi A, Girerd N, Benetos A, Frimat L, Gautier S, Weryha G, et al. Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic review and meta-analysis. J Hypertens. 2014;32:1562–71.

    CAS  PubMed  Google Scholar 

  25. Ko D, Preis SR, Lubitz SA, McManus DD, Vasan RS, hamburg NM, et al. Relation of orthostatic hypotension with new-onset atrial fibrillation (from the Framingham Heart Study). Am J Cardiol. 2018;121:596–601.

    PubMed  Google Scholar 

  26. Cremer A, Rousseau AL, Boulestreau R, Kuntz S, Tzourio C, Gosse P. Screening for orthostatic hypotension using home blood pressure measurements. J Hypertens. 2019;37:923–7.

    CAS  PubMed  Google Scholar 

  27. Cohen A, Vidal JS, Roca F, Rananja H, hernandorena I, Coude du Foresto L, et al. Feasibility and determinants of orthostatic hypotension self-measurement at home in an elderly community-dwelling population. Am J Hypertens. 2019;32:824–32.

    PubMed  Google Scholar 

  28. Belmin J, Abderrhamane M, Medjahed S, Sibony-Prat J, Bruhat A, Bojic N, et al. Variability of blood pressure response to orthostatism and reproducibility of the diagnosis of orthostatic hypotension in elderly subjects. J Gerontol A Biol Sci Med Sci. 2000;55:M667–71.

  29. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. List of authors/Task Force members:. 2018 practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2018;36:2284–309.

    CAS  PubMed  Google Scholar 

  30. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138:e484–594.

    PubMed  Google Scholar 

  31. Joint Committee for Guideline Revision. 2018 Chinese guidelines for prevention and treatment of hypertension—a report of the revision committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol. 2019;16:182–241.

    PubMed Central  Google Scholar 

  32. Blacher J, Halimi JM, Hanon O, Mourad JJ, Pathak A, Schnebert B.French Society of Hypertension et al. Management of arterial hypetension in adults: 2013 guidelines of the French Society of Arterial Hypertension. Fundam Clin Pharm.2014;28:1–9.

    CAS  Google Scholar 

  33. Stergiou GS, Giovas PP, Gkinos CP, Patouras JD. Validation of the Microlife WatchBP Home device for self home blood pressure measurement according to the International Protocol. Blood Press Monit. 2007;12:185–8.

    PubMed  Google Scholar 

  34. Ji T, Zhao Y, Wang J, Cui Y, Duan D, Chai Q, et al. Effect of low-dose statins and Apolipoprotein E genotype on cerebral small vessel disease in older hypertensive patients: a subgroup analysis of a randomized clinical trial. J Am Med Dir Assoc. 2018;19:995–1002.

    PubMed  Google Scholar 

  35. Chen Y, Yu H, Zhu J, Zhang H, Zhao Y, Dong Y, et al. Low carotid endothelial shear stress associated with cerebral small vessel disease in an older population: a subgroup analysis of a population-based prospective cohort study. Atherosclerosis. 2019;288:42–50.

    CAS  PubMed  Google Scholar 

  36. Robertson AD, Messner MA, Shirzadi Z, Kleiner-Fisman G, Lee J, Hopyan J, et al. Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders. Parkinsonism Relat Disord. 2016;22:80–86.

    PubMed  Google Scholar 

  37. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996;27:1274–82.

    PubMed  Google Scholar 

  38. SPRINT MIND Investgators for the SPRINT Research Group, Nasrallah IM, Pajewski NM, Auchus AP, Chelune G, Cheung AK, et al. Association of intensive vs standard blood pressure control with cerebral white matter lesions. JAMA. 2019;322:524–34.

    Google Scholar 

  39. Zhang H, Cui Y, Zhao Y, Dong Y, Duan D, Wang J, et al. Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial. Hypertens Res. 2019;42:717–29.

    CAS  PubMed  Google Scholar 

  40. Godin O, Tzourio C, Mailard P, Mazoyer B, Dufouil C. Antihypertnsive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation. 2011;123:266–73.

    PubMed  Google Scholar 

  41. White WB, Wakefield DB, Moscufo N, Guttmann CRG, Kaplan RF, Bohannon RW, et al. Effects of intensive versus standard ambulatory blood pressure control on cerebrovascular outcomes in older people (INFINITY). Circulation. 2019;140:1626–35.

    PubMed  Google Scholar 

  42. Kester MI, Goos JD, Teunissen CE, Benedictus MR, Bouwman FH, Wattjes MP, et al. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. JAMA. Neurol 2014;71:855–62.

    PubMed  Google Scholar 

  43. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al. Microbleeds Study Group. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165–74.

    PubMed  PubMed Central  Google Scholar 

  44. Moran C, Phan TG, Srikanth VK. Cerebral small vessel disease: a review of clinical, radiological, and histopathological phenotypes. Int J Stroke. 2012;7:36–46.

    PubMed  Google Scholar 

  45. Juraschek SP, Appel LJ, Miller ER III, Mukamal KJ, Lipsitz L. Hypertension treatment effects on orthostatic hypotension and its relationship with cardiovascular disease: results from the AASK trial. Hypertension. 2018;72:986–93.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et al. Consensus statement on the definition of orthostatic hypotension, neutrally mediated syncope and the postural tachycardia syndrome. Auto Neurosci. 2011;161:46–48.

    Google Scholar 

  47. Wilson D, Werring DJ. Antithrombotic therapy in patients with cerebral microbleeds. Curr Opin Neurol. 2017;30:38–47.

    CAS  PubMed  Google Scholar 

  48. Cheng Y, Liu J, Zhang S, Li J, Wei C, Wang D, et al. Prior antithrombotic therapy is associated with cerebral microbleeds in ischemic stroke patients with atrial fibrillation and/or rheumatic heart disease. Front Neurol. 2018;9:1184.

    PubMed  Google Scholar 

  49. Badi MK, Vilanilam GK, Gupta V, Barrett KM, Lesser ER, Cochuyt JJ, et al. Pharmacotherapy for patients with atrial fibrillation and cerebral microbleeds. J Stroke Cerebrovasc Dis. 2019;28:2159–67.

    PubMed  Google Scholar 

  50. Pan KL, Singer DE, Ovbiagele B, Wu YL, Ahmed MA, Lee M. Effects of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease: a systematic review and meta-analysis. J Am Heart Assoc. 2017;6:e005835.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank all participants and individuals who offered their assistance to this study.

Funding

This work was supported by the National Natural Science Foundation of China (grant numbers 81670432 and 81973139); Key Technology Research and Development Project of Shandong Province (grant numbers 2018GSF118044, 2017GSF218060, and 2019GSF108079); and The Innovation Project of Shandong Academy of Medical Sciences and Academic Promotion Program of Shandong First Medical University.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhendong Liu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cui, Y., Zhang, H., Zhao, Y. et al. Home-measured orthostatic hypotension associated with cerebral small vessel disease in a community-based older population. Hypertens Res 43, 798–807 (2020). https://doi.org/10.1038/s41440-020-0429-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-020-0429-x

Keywords

This article is cited by

Search

Quick links